Clinical Trials Logo

Filter by:
NCT ID: NCT06430333 Not yet recruiting - Depression Clinical Trials

Sleep to Reduce Incident Depression Effectively in Peripartum

STRIDE P
Start date: October 1, 2025
Phase: N/A
Study type: Interventional

Perinatal depression (PND) is the most common complication in pregnancy and postpartum, which increases risk for adverse perinatal outcomes such as preterm birth, maternal suicidal thoughts, and impaired mother-infant bonding. Insomnia often precedes PND cases and may serve as an entry point for interventions preventing PND. The proposed project is a large-scale clinical trial to test the effectiveness of a mindfulness-based sleep program designed for pregnant women to improve sleep and alleviate cognitive arousal to reduce risk for PND across pregnancy and postpartum.

NCT ID: NCT06430086 Not yet recruiting - Poor Sleep Quality Clinical Trials

Mechanistic Effect of Walnut Consumption on Sleep Quality

Start date: June 1, 2024
Phase: N/A
Study type: Interventional

Poor sleep quality is very common in modern society. Walnuts contain many nutrients that may be helpful for sleep, including melatonin and polyphenols. Some studies show that eating foods high in melatonin and polyphenols improves sleep quality, but walnuts have not been studied specifically. This study proposes to test if eating walnuts improves sleep compared to a food that lacks these sleep-promoting factors. The investigators expect that walnut consumption for 4 days will increase melatonin levels and lead to better sleep quality compared to a high-carbohydrate, high-sugar food. The study will enroll middle-aged and older adults with sleep complaints to participate in this study. Each person will eat the two different foods for 4 days each in random order. The 4-day periods will be separated by at least 2-3 weeks. Sleep quality will be measured by questionnaire and with a wrist monitor every day. The investigators will also do a sleep study using electroencephalography (EEG) on night 3 and take measures of circadian physiology (natural body rhythms) in the laboratory on day 4 (including overnight) by measuring body temperature and blood and urine melatonin. The study findings may provide new options to improve sleep health from increased walnut consumption.

NCT ID: NCT06429982 Not yet recruiting - Rhabdomyolysis Clinical Trials

Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols

Start date: October 1, 2024
Phase: Phase 1
Study type: Interventional

There is a significant unmet need for optimized treatment in rhabdomyolysis. There are few prospective interventional studies on treatment for rhabdomyolysis, a condition which affects diverse and underrepresented populations at a higher rate. While steroids are often used off-label, a systematic study has not yet been initiated, and steroids have not been yet considered in as a consideration to standard care guidelines. The hypothesis is that patients who receive dexamethasone in addition to standard care versus placebo and standard care will have improvement in pain, length of hospital stay, and decrease in kidney complications.

NCT ID: NCT06429813 Not yet recruiting - Clinical trials for Metastatic Prostate Cancer

Remotely Monitored Exercise Interventions in Patients With mCSPC Undergoing ADT (Prostate 006)

Start date: July 2024
Phase: N/A
Study type: Interventional

This study consists of two home-based exercise programs: a stationary exercise bicycle intervention (Arm A), and a walking intervention (Arm B). The study will enroll 24 patients who are starting ADT (Androgen Deprivation Therapy)/ARSI (Androgen-Receptor Signaling Inhibitors) therapy for newly diagnosed metastatic castrate-sensitive prostate cancer (mCSPC). All participants will be asked to complete 1-2 training sessions at UVA prior to starting the exercise. All participants will be asked to complete aerobic and strength testing before and after the exercise program. Participants will be asked to answer questionnaires throughout the program. The at-home exercise will last for 12 weeks.

NCT ID: NCT06429449 Not yet recruiting - Leukemia Clinical Trials

Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia

Start date: December 2024
Phase: Phase 1
Study type: Interventional

This is an open label, phase 1 study for AML subjects with relapsed or refractory disease or subjects in morphologic remission with MRD+ after first line therapy with venetoclax+HMA. A preliminary dose-finding cohort will be followed by 3 expansion cohorts.

NCT ID: NCT06429072 Not yet recruiting - Laminectomy Clinical Trials

Integration of Mindfulness and Acupuncture After Spine Surgery

I-MASS
Start date: June 1, 2024
Phase: N/A
Study type: Interventional

The Integration of mHealth Mindfulness and auricular Acupuncture (AA) for individuals undergoing Spine Surgery (I-MASS) is a novel combination of integrative treatments to address postsurgical pain. This is a single-site, two-arm randomized feasibility and acceptability pilot trial of the I-MASS program plus enhanced patient education compared to enhanced patient education alone in patients undergoing spine surgery. Outcomes data will come from a combination of passive electronic health record data augmented with patient-reported data collected through the Pattern Health app (the mHealth platform used for delivering mindfulness training and collecting data). Outcomes will focus on feasibility and acceptability of I-MASS, feasibility of recruitment and retention strategies, and data collection procedures through both the Lift app and electronic health record. Feasibility will be supported by mindfulness module completion rates, acupuncture visits attended, participant retention, and questionnaire completion rates. Acceptability will be supported by patient-reported satisfaction, acceptability and usability thresholds.

NCT ID: NCT06428695 Not yet recruiting - Weight Management Clinical Trials

Education Session to Improve Program Adherence

Start date: June 2024
Phase: N/A
Study type: Interventional

To examine is user knowledge of a dietary self-monitoring (DSM) calorie tracking app and improving patient adherence to daily caloric food intake to help with weight loss.

NCT ID: NCT06428630 Not yet recruiting - Oral Lichen Planus Clinical Trials

Systemic Absorption of Dexamethasone Oral Rinse in Patients With Oral Lichen Planus

Start date: September 1, 2024
Phase: Early Phase 1
Study type: Interventional

The objective of this study is to see the amount of systemic absorption of a standard dose of dexamethasone oral rinse for patients with symptomatic oral lichen planus (OLP) or oral lichenoid reactions (OLR) and healthy subjects (those who do not have OLP or OLR aka the control group).

NCT ID: NCT06428617 Not yet recruiting - Obesity Clinical Trials

Fundus Ablation Registry (Gastric Fundus Mucosal Ablation for Weight Loss)

Start date: June 2024
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to construct a multi-site, prospective registry to evaluate the clinical outcomes of patients who have undergone gastric fundus mucosal ablation at True You Weight Loss.

NCT ID: NCT06428526 Not yet recruiting - Essential Tremor Clinical Trials

Impact of Sensory Electrical Stimulation on Sensation and Tremor

Start date: July 1, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to understand the acute, short-term and long-term impact of transcutaneous and/or percutaneous electrical stimulation with afferent-specific electrical stimulation (asES) on proprioception and fine motor control in the upper extremity. For this purpose, the researchers will use transcutaneous and/or percutaneous asES, high-density electromyography (HD-EMG), arm kinematic measurements, and standardized clinical assessments. This study will be conducted in healthy able-bodied individuals and patients with essential tremor (ET).